九强生物收盘上涨1.10%，滚动市盈率16.43倍，总市值81.37亿元

Group 1 - The core viewpoint of the article highlights that Jiukang Biological has a current stock price of 13.83 yuan, with a rolling PE ratio of 16.43 times and a total market value of 8.137 billion yuan [1] - The average PE ratio for the medical device industry is 48.98 times, with a median of 36.16 times, placing Jiukang Biological at the 40th position in the industry ranking [1] - On May 9, Jiukang Biological experienced a net inflow of main funds amounting to 776,100 yuan, although it has seen a total outflow of 6.4534 million yuan over the past five days [1] Group 2 - Jiukang Biological specializes in the research, production, and sales of biochemical diagnostics, blood coagulation testing, blood type testing, and tumor pathology diagnostics [1] - The company was recognized as a "National Enterprise Technology Center" on February 22, 2023, as part of the 29th batch of newly recognized national enterprise technology centers [1] - The latest quarterly report for Q1 2025 shows that Jiukang Biological achieved an operating income of 320 million yuan, a year-on-year decrease of 18.81%, and a net profit of 83.2575 million yuan, down 30.99%, with a gross sales margin of 80.84% [1]